Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT02367781||Active, not recruiting
|A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)||
||723||All||18 Years and older (Adult, Older Adult)||NCT02367781||GO29537
|IMpower130||April 16, 2015||March 15, 2018||December 28, 2019||February 20, 2015||May 7, 2019||April 3, 2019||